Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
PGNY Stock Chart & Stats
$18.13
$0.60(3.43%)
At close: 4:00 PM EST
$18.13
$0.60(3.43%)
Day’s Range― - ―
52-Week Range$16.76 - $28.75
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.65M
Market Cap
$1.48B
Enterprise Value$1.40B
Total Cash (Recent Filing)$310.10M
Total Debt (Recent Filing)$27.73M
Price to Earnings (P/E)37.4
Beta0.57
Next Earnings
May 07, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding81,902,230
10 Day Avg. Volume1,484,724
30 Day Avg. Volume1,648,684
Financial Highlights & Ratios
PEG Ratio2.45
Price to Book (P/B)4.24
Price to Sales (P/S)1.70
P/FCF Ratio11.41
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue1.09
Enterprise Value/Gross Profit4.60
Enterprise Value/Ebitda14.29
Forecast
1Y Price Target
$27.22Price Target Upside50.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.17
Revenue Forecast (FY)$1.38B
Bulls Say, Bears Say
Bulls Say
Client RetentionExtremely high client retention and a sizable portion of customers expanding benefit usage support predictable recurring revenue and indicate potential for organic revenue growth.
Product For Smaller EmployersProgyny Select's cost-controlled pricing designed for smaller employers could broaden the addressable market and attract new commercial customers.
Profitability And Cash FlowExpanded gross margins and strong operating cash flow point to healthier underlying profitability and greater flexibility for reinvestment or shareholder returns.
Bears Say
Covered Lives And Demand RiskReductions in reported covered lives raise the risk that lower employment or client churn could depress utilization and future service demand.
Large Client LossLoss of a large customer has materially reduced revenue growth and weakened the near-term revenue outlook.
Soft Guidance And Investor SentimentSofter-than-expected forward guidance combined with a lack of near-term catalysts may keep investor sentiment cautious despite valuation appeal.
Progyny News
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $16.75 and its highest was $28.75 in the past 12 months.
What is Progyny’s market cap?
Progyny’s market cap is $1.48B.
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is May 07, 2026 which is in 45 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Feb 26, 2026. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.147 by -$0.007.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is 0.26.
How many shares outstanding does Progyny have?
Progyny has 81,902,230 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.14 in its last earnings report, missing expectations of $0.147. Following the earnings report the stock price went down -20.494%.
Which hedge fund is a major shareholder of Progyny?
Currently, no hedge funds are holding shares in PGNY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Progyny Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.22 (50.14% Upside)
$27.22 (50.14% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 493.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 11.0%
Last 30 Days ▲ 11.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.37%
12-Months-Change
Fundamentals
Return on Equity
11.37%
Trailing 12-Months
Asset Growth
22.51%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Company Deck
PGNY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Progyny had a strong performance this quarter with revenue and profitability exceeding expectations, a successful selling season, and a high client renewal rate. However, challenges included slightly lower than expected new covered lives and impact from a large client loss. Overall, the positive aspects significantly outweigh the negative, indicating strong business momentum.View all PGNY earnings summariesPGNY Stock 12 Month Forecast
Average Price Target
$27.22
▲(50.14% Upside)
Technical Analysis
Ownership Overview
2.69% Insiders
33.68% Mutual Funds
17.75% Other Institutional Investors
17.78% Public Companies and Individual Investors